Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00287040 · ClinicalTrials.gov registry record · Phase 3

Breast Cancer Screening Via Computer V. Phone

A Phase 3 study of Breast Cancer Screening, sponsored by Indiana University.

Completed
Registry status
Phase 3
Development phase
1,686
Enrollment target
2
Study locations

NCT00287040: Completed Phase 3 study of Breast Cancer Screening, sponsored by Indiana University.

NCT00287040 is a Phase 3 study of Breast Cancer Screening that has completed, run by Indiana University. The registered enrollment target is 1,686 participants, below the 63,231-participant average among 8 other Breast Cancer Screening trials with a reported enrollment target (97% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00287040, a Phase 3 study of Breast Cancer Screening, has completed, sponsored by Indiana University.

COMPLETED
Registry status
Phase 3
Development phase
1,686 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this study is to compare mammography adherence among women receiving tailored, interactive mammography interventions via DVD and telephone counseling to usual care.

Conditions Studied

Interventions

  • BEHAVIORAL Tailored, interactive intervention for mammography screening

Study Locations (2)

Indiana

  • Indiana University - Indianapolis

North Carolina

  • Duke University - Durham

Trial Details

FieldValue
Enrollment Target 1,686 participants
Start Date 2007-09
Est. Completion 2009-06
Phase Phase 3
Indiana University

890 total trials

What the finished NCT00287040 record still lists

NCT00287040 is an interventional study that assigns participants to a tested intervention. Its 1,686 participants enrollment target places it among the larger protocols in the corpus, below the 63,231-participant average among 8 other Breast Cancer Screening trials with a reported enrollment target (97% lower).

The record links to 1 condition, with Breast Cancer Screening appearing as the primary indexed condition, and to 1 intervention - of which Tailored, interactive intervention for mammography screening is the first listed.

NCT00287040 reports a single indexed study location in Indiana, North Carolina.

Frequently Asked Questions

What is clinical trial NCT00287040 about?

NCT00287040 is a clinical study titled "Breast Cancer Screening Via Computer V. Phone". The purpose of this study is to compare mammography adherence among women receiving tailored, interactive mammography interventions via DVD and telephone counseling to usual care.

What is the current status of trial NCT00287040?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,686 participants. The study started on 2007-09. Estimated completion is 2009-06.

What conditions does trial NCT00287040 study?

This clinical trial studies the following conditions: Breast Cancer Screening.

What interventions are being tested in trial NCT00287040?

The interventions under investigation include: Tailored, interactive intervention for mammography screening (BEHAVIORAL).

Who is sponsoring clinical trial NCT00287040?

This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00287040 being conducted?

This trial has 2 study locations across Indiana, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer Screening

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00287040's enrollment target sits among peer trials

1,686 4th of 8 higher than 5 of 8 other Breast Cancer Screening trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Breast Cancer Screening trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06376565 · 1,680 participants · NA

    Improving Colonoscopy Surveillance for Patients With High Risk Colon Polyps

  • NCT04321200 · 1,700 participants

    PANDA Gym: Automated Assessment of Neurodevelopment in Infants at Risk for Motor Disability

  • NCT06238622 · 1,700 participants · Phase 3

    A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast

  • NCT07284901 · 1,700 participants · Phase 3

    Efficacy and Safety of KAI-9531 Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00287040, the US trial registry maintained by the National Library of Medicine. NCT00287040 (large enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.